Vontobel Holding’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Buy
4,160
+5
+0.1% +$341 ﹤0.01% 1209
2026
Q1
$269K Buy
4,155
+365
+10% +$25.7K ﹤0.01% 1027
2025
Q4
$255K Buy
+3,790
New +$255K ﹤0.01% 1228
2025
Q3
Sell
-4,895
Closed -$255K 1385
2025
Q2
$255K Buy
4,895
+153
+3% +$8.71K ﹤0.01% 1100
2025
Q1
$303K Sell
4,742
-3,153
-40% -$183K ﹤0.01% 908
2024
Q4
$377K Buy
+7,895
New +$405K ﹤0.01% 860
2023
Q4
Sell
-6,512
Closed -$249K 1131
2023
Q3
$249K Buy
+6,512
New +$267K ﹤0.01% 944

Other funds holding HALO

Vontobel Holding's HALO Position: Q2 2026 in Review

Vontobel Holding increased its Halozyme (HALO) stake by 0.12% in Q2 2026, buying an estimated $341 and bringing the position to 4,160 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Vontobel Holding first reported a position in HALO in Q3 2023 and has held it in 7 quarters since. The position peaked at $377K in Q4 2024. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Vontobel Holding held 4,160 shares of Halozyme worth $326K as of Q2 2026.
  • Vontobel Holding bought 5 Halozyme shares in Q2 2026, an estimated $341.
  • Halozyme made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1209 holding.
  • Vontobel Holding first reported a position in Halozyme in Q3 2023 and has held it in 7 quarters since.
  • Vontobel Holding's Halozyme position peaked at $377K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.